Review • Journal • IO biomarker
|
BCL2 (B-cell CLL/lymphoma 2) • CD34 (CD34 molecule) • VIM (Vimentin) • STAT6 (Signal transducer and activator of transcription 6) • CD99 (CD99 Molecule) • NAB2 (NGFI-A Binding Protein 2)
|
CD34 positive
|
imatinib • Halaven (eribulin mesylate) • Inlyta (axitinib) • figitumumab (CP-751,871)